Literature DB >> 1140825

Immunogenicity of lipid-conjugated protein in the intestine.

R V Heatley, J M Stark.   

Abstract

Acylation of human serum albumin increases its ability to stimulate antibody formation in rats. This can be shown not only when the antigen was given intramuscularly but also when administered by injection into the lumen of the gut. A tendency of the modified molecules to attach to cells and to aggregate, increased anti-complementary activity, and reduced drainage through the lymphatics, have been demonstrated. The relationship of these features to the increased immunogenicity is discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1140825      PMCID: PMC1445869     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  15 in total

1.  Antibodies to cow's milk proteins. Their presence and significance.

Authors:  R D PETERSON; R A GOOD
Journal:  Pediatrics       Date:  1963-02       Impact factor: 7.124

2.  Specific inhibition of antibody production. II. Paralysis induced in adult mice by small quantities of protein antigen.

Authors:  D W DRESSER
Journal:  Immunology       Date:  1962-05       Impact factor: 7.397

3.  Effectiveness of lipid and lipidophilic substances as adjuvants.

Authors:  D W DRESSER
Journal:  Nature       Date:  1961-09-16       Impact factor: 49.962

4.  Circulating antibodies to milk proteins in ulcerative colitis.

Authors:  K B TAYLOR; S C TRUELOVE
Journal:  Br Med J       Date:  1961-10-07

5.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

6.  Intestinal lymph as pathway for transport of absorbed fatty acids of different chain lengths.

Authors:  B BLOOM; I L CHAIKOFF
Journal:  Am J Physiol       Date:  1951-08

7.  Role of complement in induction of the allergic response.

Authors:  M B Pepys
Journal:  Nat New Biol       Date:  1972-05-31

8.  Determination of free amino groups in proteins by trinitrobenzenesulfonic acid.

Authors:  A F Habeeb
Journal:  Anal Biochem       Date:  1966-03       Impact factor: 3.365

9.  Hypothesis. Bound C3 as the second signal for B-cell activation.

Authors:  P Dukor; K U Hartmann
Journal:  Cell Immunol       Date:  1973-06       Impact factor: 4.868

10.  Interactions of the complement system with native and chemically modified endotoxins.

Authors:  H Gewurz; S E Mergenhagen; A Nowotny; J K Phillips
Journal:  J Bacteriol       Date:  1968-02       Impact factor: 3.490

View more
  6 in total

1.  The effects of splenectomy, mesenteric lymphadenectomy and portacaval shunt on antibody responses to antigens within the small intestine.

Authors:  R V Heatley; J M Stark; R H Whitehead; J Locke; T O'Donovan
Journal:  Immunology       Date:  1977-04       Impact factor: 7.397

Review 2.  Mucosal immunology.

Authors:  J Bienenstock; A D Befus
Journal:  Immunology       Date:  1980-10       Impact factor: 7.397

3.  Immunogenicity of lipid-conjugated antigens. II. Anti-complementary activity and antigen trapping in the spleen.

Authors:  J M Stark; N Matthews; J Locke
Journal:  Immunology       Date:  1980-03       Impact factor: 7.397

4.  The effects of surgical removal of Peyer's patches in rat on systemic antibody responses to intestinal antigen.

Authors:  E V Heatley; J M Stark; P Horsewood; E Bandouvas; F Cole; J Bienenstock
Journal:  Immunology       Date:  1981-11       Impact factor: 7.397

5.  Immunogenicity of lipid-conjugated antigens. I. The influence of chain length and degree of conjugation on induction of antibody in mice.

Authors:  J M Stark; J Locke; R V Heatley
Journal:  Immunology       Date:  1980-03       Impact factor: 7.397

6.  Similarity between the 38-kilodalton lipoprotein of Treponema pallidum and the glucose/galactose-binding (MglB) protein of Escherichia coli.

Authors:  P S Becker; D R Akins; J D Radolf; M V Norgard
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.